Brainsway is a leader in non-invasive treatments for brain disorders utilizing Deep Transcranial Magnetic Stimulation (Deep TMS). Brainsway’s unique patented technology was developed in collaboration with the National Institute of Health and is FDA and CE cleared to treat clinical depression and obsessive-compulsive disorder (OCD) in adults.
- eToro Group Ltd.
- Minute Media Inc.
- Tomorrow.io
- Alpha TAU Medical Ltd.
- Ayala Pharmaceuticals Inc.
- Brainsway Ltd.
- Chemomab Therapeutics Ltd.
- Elbit Vision Systems Ltd.
- Foamix Pharmaceuticals Ltd.
- Galooli Ltd.
- Gamida Cell Ltd.
- Intec Pharma Ltd.
- Kahr Medical Ltd.
- Kamada Ltd.
- Lightricks Ltd.
- Mapi Pharma Ltd.
- MeMed Diagnostics Ltd.
- Polus Tech Pty Ltd.
- PolyPid Ltd.
- ReWalk Robotics Ltd.
- SuperDerivatives Inc.
- Syqe Medical Ltd.
- Tipa Corp. Ltd.
- Trax Ltd.
- Veev
- Yotpo Ltd.
- Other